TradeFlare's AI research teams analysed CRNX on 7 market nights between July 10, 2026 and September 2, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 2, 2026 | HOLD | $84.95 | — / — | not yet | not yet | The stock is at a critical resistance level with mixed technical signals and an acquisition cap. |
| September 1, 2026 | BUY | $84.95 | $101.94 / $72.21 | not yet | not yet | The acquisition news provides a clear catalyst and the technicals suggest continuation. |
| August 21, 2026 | BUY | $84.69 | — / — | not yet | not yet | The market regime is neutral, and the fundamental and risk assessments for CRNX are strongly bearish, outweighing the bullish technicals. |
| July 15, 2026 | BUY | $83.71 | — / — | not yet | not yet | Vertex Pharmaceuticals' pending acquisition for $85 per share. |
| July 14, 2026 | HOLD | $83.67 | — / — | not yet | not yet | Pending acquisition by Vertex Pharmaceuticals provides a floor and potential upside. |
| July 13, 2026 | BUY | $83.58 | $105.00 / $70.90 | not yet | not yet | The post-earnings drift signal suggests momentum will continue for a few weeks. |
| July 10, 2026 | BUY | $83.62 | $100.34 / $71.08 | not yet | not yet | The acquisition is expected to close in Q4, providing a defined timeframe for the trade. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.